Full Name | Tierra Yonker |
---|---|
Gender | Female |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | N4590 Hwy 45, Eden, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265107379 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 13122-121 (Wisconsin) | Secondary |
101YA0400X | Counselor - Addiction (substance Use Disorder) | 16047-132 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tierra Yonker, N4590 Hwy 45, Eden, WI 53019-1212 Ph: (920) 904-6445 | Tierra Yonker, N4590 Hwy 45, Eden, WI 53019-1212 Ph: (920) 904-6445 |
News Archive
Effective June 22, 2010, the most popular selling cigarettes – light cigarettes – will be phased out as part of the Family Smoking Prevention and Tobacco Control Act, which was signed into law on June 22, 2009. This historic day provides an opportunity for the 70 percent of smokers who want to quit to finally end their addiction to these deadly products.
When patients undergo diagnostic lab tests as part of the inpatient admission process, they may wonder why or how physicians choose particular tests. Increasingly, medical professionals are using electronic medical systems that provide lists of lab tests from which medical professionals can choose.
"During these tough budget times, citizens across the world rightfully question the effectiveness of government spending, including funds spent on foreign assistance," Daniel Yohannes, chief executive officer of the Millennium Challenge Corporation (MCC), writes in this Foreign Policy opinion piece.
A study reported in the current issue of Cancer, the journal of the American Cancer Society, shows that obesity is linked to lower levels of prostate specific antigen (PSA) in men, making early detection tests unreliable.
Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.
› Verified 4 days ago